QPPV.COM KNOWLEDGE ASSESSMENT

GVP Module VI: Difficult ICSR Validity and Assessment Scenarios

Test your understanding of the concepts covered by GVP Module VI: Difficult ICSR Validity and Assessment Scenarios.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A vague source states only, "The patient experienced an adverse event." What should the processor do?

Replace the phrase with the most likely diagnosis based on the product's known risks Treat the phrase as sufficient evidence of a specific reaction such as nausea Assess whether the nonspecific statement satisfies the applicable criteria and seek clarification where possible Discard the report because nonspecific terms have no pharmacovigilance value

Question 2 of 10 Which statement best describes the relationship between validity and completeness?

A valid ICSR is necessarily clinically complete A case cannot be valid until diagnosis, outcome and causality are fully established Validity means the minimum criteria are met; further information may still materially improve the case Completeness is irrelevant once a case has passed minimum validation

Question 3 of 10 An initial report contains an identifiable reporter, product and clinical event, but insufficient patient-identifying information. Follow-up later provides adequate patient information. What should occur?

The later information should be ignored because validity is fixed at first receipt The case should be reassessed and may become a valid ICSR once the missing minimum element is obtained A new unrelated case must always be created The original report must remain permanently classified as invalid

Question 4 of 10 A report describes an elevated ALT after Product D was started but provides no diagnosis or explicit statement about causality. What is the most defensible assessment?

Assume drug-induced liver injury because the timing is compatible Ignore the result because laboratory data can never constitute an event Assess whether the reported laboratory abnormality itself is the clinical event and avoid assuming causality or diagnosis Code hepatic failure because it is the most serious possible interpretation

Question 5 of 10 A source reports a confirmed diagnosis but does not identify any medicinal product as suspected. What is the key validity issue?

The diagnosis alone establishes a valid ICSR The report is valid if the diagnosis is serious A suspected medicinal product is still required; a diagnosis alone does not establish a product-related case The processor should select the product most commonly associated with the diagnosis

Question 6 of 10 Which documentation would provide the strongest audit trail for a case that became valid after follow-up?

Only the final case status, with no record of earlier uncertainty The original incomplete information, the initial validity rationale, the follow-up obtained and the reason the status changed A note stating "validated after review" without supporting details A replacement record containing only the newly obtained information

Question 7 of 10 A report describes events in "several patients" but gives no information that distinguishes any individual patient. What should the processor recognise?

Each event automatically represents an identifiable patient A population reference does not automatically establish an identifiable individual patient The reporter can be treated as the patient for validity purposes The number of patients can be used to satisfy patient identifiability

Question 8 of 10 Which decision sequence most closely reflects the article's practical validity framework?

Assess seriousness, assign causality, determine expectedness, then identify the patient Identify the patient, identify the reporter, confirm a suspected product, then assess for a reported reaction or other qualifying clinical event Identify the product, infer the likely reaction, confirm hospitalisation, then identify the reporter Confirm a fatal or serious outcome, then treat the report as valid regardless of other information

Question 9 of 10 Which combination represents the four minimum elements required for a valid ICSR under the framework described?

An identifiable reporter, an identifiable patient, a suspected medicinal product and a suspected adverse reaction A serious outcome, a hospital admission, a product complaint and a known causality assessment A patient, a product, a laboratory abnormality and a medically confirmed diagnosis A reporter, a product, a treatment indication and a documented treatment failure

Question 10 of 10 A known physician reports that an identifiable patient died while receiving Product B, but provides no cause of death or preceding clinical event. Which action best reflects the article's approach?

Code death as the adverse reaction and close the case Enter an unspecified fatal reaction because the outcome is serious Record the available information, assess the minimum criteria without inventing a cause, and consider appropriate follow-up Assume the product caused the death because exposure preceded the outcome

GVP Module VI: Difficult ICSR Validity and Assessment Scenarios

Cookie Settings